Publications by authors named "F Spertini"

Claim this Profile
A
A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland.
Juliette Besson, Régine Audran, Maxime Karlen, Alix Miauton, Hélène Maby-El Hajjami, François Spertini

BMC Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.
Régine Audran, Olfa Karoui, Laura Donnet, Vassili Soumas, Fady Fares, François Spertini

J Infect· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.
R Audran, H Chtioui, A C Thierry, C E Mayor, L Vallotton, F Spertini

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study.
Alix Miauton, Régine Audran, Juliette Besson, Hélène Maby-El Hajjami, Maxime Karlen, François Spertini

EBioMedicine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database.
Gemma Lepri, Cosimo Bruni, Lorenzo Tofani, Alberto Moggi-Pignone, Martina Orlandi, Francois Spertini

Diagnostics (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis